Author:
Winkler Gian C.,Barle Ester Lovsin,Galati Giuseppe,Kluwe William M.
Subject
Toxicology,General Medicine
Reference68 articles.
1. The mutagenic activity of razoxane (ICRF 159): an anticancer agent;Albanese;Br. J. Cancer,1985
2. The proteasome: a novel target for cancer chemotherapy;Almond;Leukemia,2002
3. ANVISA Resolution RDC No. 17 of April 16, 2010. Technical Regulation of Good Manufacturing Practices of Drugs. 8th part. Ministério da Saúde, Diretoria Colegiada da Agência Nacional de Vigilância Sanitária, Setor de Indústria e Abastecimento (SIA) – Trecho 5, Área Especial 57, Brasília (DF).
4. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs;ASHP;Am. J. Health. Syst. Pharm.,2006
5. Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer;Barok;Cancer Lett.,2011